Angiotensin II (3-8), human (TFA)
Angiotensin II (3-8), human (TFA) is a less effective agonist at the angiotensin AT1 receptor.
Product Specifications
UNSPSC
12352209
Target
Angiotensin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease; Endocrinology
Assay Protocol
https://www.medchemexpress.com/Angiotensin_II__3-8_,_human_TFA.html
Purity
99.90
Solubility
H2O : 50 mg/mL (ultrasonic)
Smiles
O=C(O)C(F)(F)F.O=C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC2=CNC=N2)C(N3[C@@H](CCC3)C(N[C@@H](CC4=CC=CC=C4)C(O)=O)=O)=O)=O)=O)[C@H](C(C)C)N
Molecular Formula
C42H55F3N8O10
Molecular Weight
888.93
References & Citations
[1]Gardiner SM, et al. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol. 1993 Sep;110 (1) :159-62.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Launched
Isoform
AT1 Receptor
Citation 01
Theranostics. 2021 Jul 25;11 (18) :8624-8639.|Eur J Pharmacol. 2019 Jun 15:853:93-102.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
